Abstract
The review deals with urinary incontinence in climacteric women. Urinary incontinence, an involuntary/uncontrolled leakage of urine, affects up to fifty percent of women at some point in their lives.
The groups with the highest risk are peri- and postmenopausal women. The gradual loss of ovarian function results in decreased oestrogen levels.
Oestrogen deficiency causes the tissues of the uropoietic system to atrophy with all its implications, including the development or impairment of urinary incontinence. Oestrogen hormone replacement therapy has been shown to have a positive impact on increasing the quality of life of patients as well as improving their complaints, whether in monotherapy or in combination with other treatment options for incontinence.